Skip to the page content
Passes our checks

Society for Immunotherapy of Cancer Inc

EIN 39-1554806 · Milwaukee, WI

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthGood79 out of 100GovernanceStrong100 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

TO IMPROVE CANCER PATIENT OUTCOMES BY ADVANCING THE SCIENCE, DEVELOPMENT AND APPLICATION OF CANCER IMMUNOLOGY AND IMMUNOTHERAPY THROUGH OUR CORE VALUES OF INTERACTION/INTEGRATION, INNOVATION, TRANSLATION, DIVERSITY AND INCLUSION AND LEADERSHIP IN THE FIELD. SITC AIMS TO MAKE CANCER IMMUNOTHERAPY A STANDARD OF CARE AND THE WORD "CURE" A REALITY FOR CANCER PATIENTS EVERYWHERE.

Income
$12.8 million
Spending
$14.1 million
Spent on programs
85%
Reserves
14.6 months of spending
Largest source of income
fees for its services, 78%
Employees
0
Volunteers
259
Highest pay
$2,000, director

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Good: 79 out of 100.

  • Reserves

    35 of 35

    Spendable reserves would cover 14.6 months of spending.

  • Debt

    20 of 20

    It owes 7% of what it owns.

  • Living within its means

    4 of 15

    Spending exceeded income by 10% of income.

  • Income trend

    5 of 15

    Income fell 16% on the year before.

  • Spending floor

    15 of 15

    85% of spending went to programs and raising each dollar of donations cost 2 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 100 out of 100.

  • Independent board

    25 of 25

    13 of 13 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (4)
  1. $6.3 million spent. THE SOCIETY FOR IMMUNOTHERAPY OF CANCER'S (SITC) 39TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS (SITC 2024) PROVIDED A MULTIDISCIPLINARY EDUCATIONAL AND INTERACTIVE ENVIRONMENT FOCUSED ON IMPROVING THE OUTCOME FOR CURRENT AND FUTURE PATIENTS WITH CANCER BY INCORPORATING STRATEGIES BASED ON BASIC AND APPLIED CANCER IMMUNOTHERAPY. THE ANNUAL MEETING CONSISTED OF CUTTING-EDGE RESEARCH PRESENTATIONS BY EXPERTS IN THE FIELD, ORAL AND POSTER ABSTRACT PRESENTATIONS AND AMPLE OPPORTUNITY FOR STRUCTURED AND INFORMAL DISCUSSIONS, INCLUDING IMPORTANT NETWORKING OPPORTUNITIES. IN ADDITION, THE MEETING INCLUDES UPDATES ON MAJOR NATIONAL AND INTERNATIONAL INITIATIVES COMING FROM ACADEMIA, GOVERNMENT AND INDUSTRY, AS WELL AS IMPORTANT SOCIETY PROJECTS.
  2. $618,457 spent. CIG PROGRAM - THE SITC CANCER IMMUNOTHERAPY GUIDELINES PROGRAM IS A COLLECTION OF CLINICAL PRACTICE GUIDELINES (CPGS) DEVELOPED BY MULTI-DISCIPLINARY PANELS OF EXPERTS WHO DRAW FROM THEIR OWN PRACTICAL EXPERIENCE AS WELL AS EVIDENCE IN THE PUBLISHED LITERATURE AND CLINICAL TRIAL DATA TO DEVELOP EVIDENCE- AND CONSENSUS-BASED RECOMMENDATIONS ON WHEN AND HOW TO USE IMMUNOTHERAPY TO HELP IMPROVE OUTCOMES FOR PATIENTS WITH CANCER. THESE CPGS OFFER A VITAL RESOURCE FOR THE PRACTICING ONCOLOGY COMMUNITY. SITC USES AS A MODEL THE INSTITUTE OF MEDICINE'S 2011 "STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES" TO ENSURE A FAIR, TRANSPARENT AND BALANCED PROCESS FOR CREATING THE CPGS. EACH CPG EXPERT PANEL IS COMPRISED OF A COMPREHENSIVE MIX OF ACADEMIC PHYSICIANS AND RESEARCHERS, NURSES, PATIENTS, AND PATIENT ADVOCATES INVITED FROM INSTITUTIONS ACROSS THE UNITED STATES.
  3. $354,970 spent. THE ADVANCES IN CANCER IMMUNOTHERAPY (ACI) SERIES HOSTED TEN CME-, CNE-, CPE-, AND MOC- CERTIFIED PROGRAMS IN 2024. TWO OF THE PROGRAMS WERE HELD IN PERSON AT SUBSPECIALTY GROUP MEETINGS, AND EIGHT OF THE PROGRAMS WERE HELD VIRTUALLY ONLY. THE SERIES WAS DESIGNED TO PROVIDE EDUCATION TO PATIENT CARE PROVIDERS AND OTHERS WHO WISH TO LEARN THE BASIC PRINCIPLES OF TUMOR IMMUNOLOGY AND IMMUNOTHERAPY, AND TO IMPROVE THEIR ABILITY TO INTEGRATE IMMUNOTHERAPY INTO STATE-OF-THE-ART CLINICAL MANAGEMENT FOR THEIR PATIENTS. THIS INTENDED AUDIENCE INCLUDED CLINICAL ONCOLOGISTS, REGISTERED NURSES, ADVANCED PRACTITIONERS, PHARMACISTS, EMERGENCY PHYSICIANS, PATHOLOGISTS, SURGEONS, RADIATION ONCOLOGISTS, ALLIED HEALTH PROFESSIONALS, AND OTHER PATIENT CARE PROVIDERS, STUDENTS AND PATIENT ADVOCATES.
  4. $4.7 million spent. WORKSHOP / CONNECTED / PRIMER / WIC/ INDUSTRY / WINTER / WIN / SPAKATHON PROGRAM / JOURNAL / COLLABORATIVE EDUCATION PROGRAMS / CIG / POLICY ACTIVITIES / SCIENTIFIC RESOURCES / CERTIFICATE PROGRAM / DIVERSITY, EQUITY AND INCLUSION / ENGINEERING AND IO / FAIO / OTHER PROGRAM SERVICES

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since August 1993.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.